Journal profile · Psychiatry
Journal of Clinical Psychopharmacology
ISSN 0271-0749 · eISSN 1533-712X · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1981
Journal of Clinical Psychopharmacology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.82; JCR Q2 (journal website); hybrid open access; median 97 days to acceptance (71 articles, last 24 months); community-reported acceptance: moderate; 171 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Clinical Psychopharmacology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Schizophrenia research and treatment, Treatment of Major Depression and Electroconvulsive Therapy Studies, together about 41.8% of its articles. Its main subfields are Psychiatry and Mental health. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
Source: LetPub
Research area (LetPub): Psychiatry
Editor-in-chief Anthony J. RothschildPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Schizophrenia research and treatmentMedicine17.8%
- Treatment of Major DepressionMedicine14.2%
- Electroconvulsive Therapy StudiesMedicine9.8%
- Bipolar Disorder and TreatmentMedicine9.7%
- Epilepsy research and treatmentMedicine4.9%
- Pharmacological Effects and Toxicity StudiesMedicine4.6%
- Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychology4.2%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Psychiatry | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · PHARMACOLOGY & PHARMACY · rank 173/356
- JCR Q2 · PSYCHIATRY · rank 119/293
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.82LetPub ·
- Impact factor (publisher)
- 3Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- SJR 2026-06
- 0.52LetPub ·
- SNIP 2026-06
- 0.83LetPub ·
- h-index
- 113LetPub ·
- h-index
- 163OpenAlex ·
- i10-index
- 3,978OpenAlex ·
- 2-year mean citedness
- 1.83OpenAlex ·
- Self-citation rate
- 13.8%LetPub ·
- Share of gold OA articles
- 19.25%LetPub ·
Volume
- Articles per year
- 66LetPub ·
Articles by year OpenAlex count · 8,220 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 138 | 23 | 40 |
| 2025 | 171 | 23 | 325 |
| 2024 | 146 | 23 | 466 |
| 2023 | 148 | 23 | 568 |
| 2022 | 135 | 27 | 798 |
| 2021 | 177 | 28 | 1,564 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
97 daysMedian, submission to acceptance · P25–P75 67 days – 125 days
- Acceptance to online
- median 60 days (71 articles)
- Submission to online
- median 166 days
- Sample
- 71 articles with submission and acceptance dates (343 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1981
- ISSN
- 0271-0749
- Electronic ISSN
- 1533-712X
- Latest issue on the website
- Volume 46, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Clinical Psychopharmacology
What CAS zone is Journal of Clinical Psychopharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Clinical Psychopharmacology is in Zone 3 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy / Psychiatry. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Clinical Psychopharmacology?
The latest impact factor listed by LetPub is 2.82; CiteScore 3.9, h-index 163.
How long does peer review take at Journal of Clinical Psychopharmacology?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 97 days (interquartile range 67–125 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Clinical Psychopharmacology in?
The journal's website gives JCR Q2; by category, PHARMACOLOGY & PHARMACY Q2 (173/356), PSYCHIATRY Q2 (119/293). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Which databases index Journal of Clinical Psychopharmacology?
According to LetPub and DOAJ records, Journal of Clinical Psychopharmacology is indexed in SCIE and Scopus.
Is Journal of Clinical Psychopharmacology open access, and what is the APC?
Journal of Clinical Psychopharmacology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .